Lumanity Strategy & Insight’s Post

We are pleased to announce that we have reorganized and expanded our strategic consulting capabilities! Our Strategy Consulting team blends essential cross-functional scientific, clinical, regulatory, and commercial perspectives to help our clients navigate the web of complex decisions and positions their assets and organizations for success. Our experts work across therapeutic areas and throughout the product lifecycle to develop fit-for-purpose, strategic solutions at the asset, portfolio, and corporate levels; evaluate opportunities; and set direction to transform ideas into action. Read more about this exciting news in our recent press release. https://lnkd.in/eEjanD5R #strategyconsulting #commercialization #regulatoryaffairs #medicalaffairs #biotech #biopharma #clinicalresearch

We are pleased to announce that we have reorganized and expanded our strategic consulting capabilities! Our Strategy Consulting team blends essential cross-functional scientific, clinical, regulatory, and commercial perspectives to help our clients navigate the web of complex decisions and positions their assets and organizations for success. Our experts work across therapeutic areas and throughout the product lifecycle to develop fit-for-purpose, strategic solutions at the asset, portfolio, and corporate levels; evaluate opportunities; and set direction to transform ideas into action. Read more about this exciting news in our recent press release. https://lnkd.in/eEjanD5R #strategyconsulting #commercialization #regulatoryaffairs #medicalaffairs #biotech #biopharma #clinicalresearch

The pharmaceutical industry has long faced a significant challenge -- the complexity of the clinical development process. Traditional methods that rely on multiple technology solutions to manage various activities have proven to be inadequate, and taking a unified platform approach is more crucial than ever. In this webinar, Srinivas (Srini) Shankar, Chief Commercial Officer, Americas and Global Head of Life Science joined other industry thought leaders from AbbVie Boehringer Ingelheim and Gilead Sciences to explore how pharma companies are beginning to converge their clinical development systems to enable a new, transformational clinical model and turn patient-focused innovations into life-changing treatments. Listen to the webinar replay to hear their perspectives on how an end-to-end platform can: • Streamline and integrate systems for seamless collaboration across key functional areas • Accelerate clinical development while maintaining high quality standards • Centralize and standardize data for efficient and efficacious decision-making #LifeSciences #Pharma #ClinicalDevelopment

The pharmaceutical industry has long faced a significant challenge -- the complexity of the clinical development process. Traditional methods that rely on multiple technology solutions to manage various activities have proven to be inadequate, and taking a unified platform approach is more crucial than ever. In this webinar, Srini Shankar, Chief Commercial Officer, Americas and Global Head of Life Sciences at Cognizant, joined other industry thought leaders from AbbVie, Boehringer Ingelheim and Gilead to explore how pharma companies are beginning to converge their clinical development systems to enable a new, transformational clinical model and turn patient-focused innovations into life-changing treatments. Listen to the webinar replay to hear their perspectives on how an end-to-end platform can: • Streamline and integrate systems for seamless collaboration across key functional areas • Accelerate clinical development while maintaining high quality standards • Centralize and standardize data for efficient and efficacious decision-making #LifeSciences #Pharma #ClinicalDevelopment

The pharmaceutical industry has long faced a significant challenge -- the complexity of the clinical development process. Traditional methods that rely on multiple technology solutions to manage various activities have proven to be inadequate, and taking a unified platform approach is more crucial than ever. In this webinar, Srini Shankar, Chief Commercial Officer, Americas and Global Head of Life Sciences at Cognizant, joined other industry thought leaders from AbbVie, Boehringer Ingelheim and Gilead to explore how pharma companies are beginning to converge their clinical development systems to enable a new, transformational clinical model and turn patient-focused innovations into life-changing treatments. Listen to the webinar replay to hear their perspectives on how an end-to-end platform can: • Streamline and integrate systems for seamless collaboration across key functional areas • Accelerate clinical development while maintaining high quality standards • Centralize and standardize data for efficient and efficacious decision-making #LifeSciences #Pharma #ClinicalDevelopment

The pharmaceutical industry has long faced a significant challenge -- the complexity of the clinical development process. Traditional methods that rely on multiple technology solutions to manage various activities have proven to be inadequate, and taking a unified platform approach is more crucial than ever. In this webinar, Srini Shankar, Chief Commercial Officer, Americas and Global Head of Life Sciences at Cognizant, joined other industry thought leaders from AbbVie, Boehringer Ingelheim and Gilead to explore how pharma companies are beginning to converge their clinical development systems to enable a new, transformational clinical model and turn patient-focused innovations into life-changing treatments. Listen to the webinar replay to hear their perspectives on how an end-to-end platform can: • Streamline and integrate systems for seamless collaboration across key functional areas • Accelerate clinical development while maintaining high quality standards • Centralize and standardize data for efficient and efficacious decision-making #LifeSciences #Pharma #ClinicalDevelopment

✨ **Attention Biopharma Leaders! 💻 Let's explore more efficient ways to generate evidence across the biopharma value chain in a dynamic manner that showcases value. 📢 Biopharma Leaders, it's time to incorporate integrated evidence tools to streamline processes and unlock benefits across various sectors in the industry. ☑️ **Elevate Commercial Operations**: ℹ️ Gain in-depth insights into market trends, patient preferences, and competitive landscapes. ℹ️ Fine-tune commercial strategies and tailor marketing initiatives. ☑️ **Enhance Market Access Strategies**: ℹ️ Highlight the value of products to payers and stakeholders. ℹ️ Strengthen market access strategies and improve patient access to treatments. ☑️ **Empower Clinical Advancements**: ℹ️ Accelerate clinical trials and optimize patient recruitment. ℹ️ Enhance data quality for faster development of revolutionary therapies. ☑️ **Leverage Real-World Evidence (RWE) Insights**: ℹ️ Deepen understanding of treatment outcomes and patient populations. ℹ️ Refine treatment protocols and guide regulatory decisions. ☑️ **Optimize Pharmacovigilance Practices**: ℹ️ Monitor drug safety and detect adverse events effectively. ℹ️ Improve signal detection capabilities and enhance patient safety outcomes. ☑️ **Streamline Supply Chain Management**: ℹ️Fine-tune inventory management and enhance demand forecasting accuracy. ℹ️ Streamline distribution efficiency and bolster supply chain resilience. 💪 Let's harness the power of integrated evidence tools to drive innovation, improve patient outcomes, and shape the future of healthcare. Embrace dynamic evidence generation practices for a transformative impact across the biopharma industry. 💻 Are you ready to champion a data-driven approach and amplify your organization's influence through integrated evidence tools? Join us in propelling the industry forward and delivering value across all facets of biopharma. The time for action is now! #BiopharmaInnovation #IntegratedEvidenceTools #DynamicEvidenceGeneration

The pharmaceutical industry has long faced a significant challenge -- the complexity of the clinical development process. Traditional methods that rely on multiple technology solutions to manage various activities have proven to be inadequate, and taking a unified platform approach is more crucial than ever. In this webinar, Srini Shankar, Chief Commercial Officer, Americas and Global Head of Life Sciences at Cognizant, joined other industry thought leaders from AbbVie, Boehringer Ingelheim and Gilead to explore how pharma companies are beginning to converge their clinical development systems to enable a new, transformational clinical model and turn patient-focused innovations into life-changing treatments. Listen to the webinar replay to hear their perspectives on how an end-to-end platform can: • Streamline and integrate systems for seamless collaboration across key functional areas • Accelerate clinical development while maintaining high quality standards • Centralize and standardize data for efficient and efficacious decision-making #LifeSciences #Pharma #ClinicalDevelopment

Follow #IQVIA’s newest showcase page and learn how IQVIA Commercial Solutions power life sciences commercialization journeys to maximize prescriber uptake and patient impact. #LifeSciences #Pharma #Commercialization https://bit.ly/3Q4GAdq

The pharmaceutical industry has long faced a significant challenge -- the complexity of the clinical development process. Traditional methods that rely on multiple technology solutions to manage various activities have proven to be inadequate, and taking a unified platform approach is more crucial than ever. In this webinar, Srini Shankar, Chief Commercial Officer, Americas and Global Head of Life Sciences at Cognizant, joined other industry thought leaders from AbbVie, Boehringer Ingelheim and Gilead to explore how pharma companies are beginning to converge their clinical development systems to enable a new, transformational clinical model and turn patient-focused innovations into life-changing treatments. Listen to the webinar replay to hear their perspectives on how an end-to-end platform can: • Streamline and integrate systems for seamless collaboration across key functional areas • Accelerate clinical development while maintaining high quality standards • Centralize and standardize data for efficient and efficacious decision-making #LifeSciences #Pharma #ClinicalDevelopment